Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Daly

Showing results (401-410 of 511) with videos related to

Pageof 52
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in OncologyTherese B Bevers, Mark Helvie, Ermelinda Bonaccio, et al.
Journal of the National Cancer Institute|March 1, 2018
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test ResultsAngela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
Clinical Genetics|November 13, 2018
Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone studyNina Beri, Linda J Patrick-Miller, Brian L Egleston, et al.
JCO Precision Oncology|December 11, 2019
Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone StudyMichael J Hall, Linda J Patrick-Miller, Brian L Egleston, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 8, 2020
Longitudinal follow-up after telephone disclosure in the randomized COGENT studyMadison K Kilbride, Brian L Egleston, Michael J Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Breast Cancer Risk Reduction, Version 2.2015Therese B Bevers, John H Ward, Banu K Arun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, et al.
Pageof 52

Showing results (401-410 of 511) with videos related to

Sort By:
Pageof 52
Journal of the National Comprehensive Cancer Network : JNCCN|November 17, 2018
Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in OncologyTherese B Bevers, Mark Helvie, Ermelinda Bonaccio, et al.
Journal of the National Cancer Institute|March 1, 2018
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test ResultsAngela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 7, 2011
Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal statusSteven J Skates, Phuong Mai, Nora K Horick, et al.
Clinical Genetics|November 13, 2018
Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone studyNina Beri, Linda J Patrick-Miller, Brian L Egleston, et al.
JCO Precision Oncology|December 11, 2019
Use and Patient-Reported Outcomes of Clinical Multigene Panel Testing for Cancer Susceptibility in the Multicenter Communication of Genetic Test Results by Telephone StudyMichael J Hall, Linda J Patrick-Miller, Brian L Egleston, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 8, 2020
Longitudinal follow-up after telephone disclosure in the randomized COGENT studyMadison K Kilbride, Brian L Egleston, Michael J Hall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2015
Breast Cancer Risk Reduction, Version 2.2015Therese B Bevers, John H Ward, Banu K Arun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, et al.
Pageof 52